share_log

Johnson & Johnson | SC 13G: Statement of acquisition of beneficial ownership by individuals-Johnson & Johnson(10.7%),Johnson & Johnson Innovation-JJDC, Inc.(10.7%)

SEC announcement ·  Apr 11 05:17
Summary by Futu AI
Johnson & Johnson, through its subsidiary Johnson & Johnson Innovation-JJDC, Inc., has filed a Schedule 13G with the Securities and Exchange Commission on April 10, 2024, indicating a significant ownership stake in Contineum Therapeutics, Inc. The filing reveals that Johnson & Johnson Innovation-JJDC, Inc. beneficially owns 1,979,173 shares of Contineum Therapeutics' Class A Common Stock, which represents 10.7% of the class. This ownership level was based on the number of shares outstanding after Contineum Therapeutics' initial public offering on April 9, 2024. The filing was made pursuant to Rule 13d-1(c) and indicates that the shares are not held with the purpose of changing or influencing the control of the issuer, nor in connection with any transaction having such purpose or effect.
Johnson & Johnson, through its subsidiary Johnson & Johnson Innovation-JJDC, Inc., has filed a Schedule 13G with the Securities and Exchange Commission on April 10, 2024, indicating a significant ownership stake in Contineum Therapeutics, Inc. The filing reveals that Johnson & Johnson Innovation-JJDC, Inc. beneficially owns 1,979,173 shares of Contineum Therapeutics' Class A Common Stock, which represents 10.7% of the class. This ownership level was based on the number of shares outstanding after Contineum Therapeutics' initial public offering on April 9, 2024. The filing was made pursuant to Rule 13d-1(c) and indicates that the shares are not held with the purpose of changing or influencing the control of the issuer, nor in connection with any transaction having such purpose or effect.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.